Scenesse Implant
Product Images NDC 73372-0116

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Scenesse (NDC 73372-0116). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Clinuvel Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label Principal Display Panel (Pdp)

SCENESSE (afamelanotide) implant 16 mg subcutaneous implant label displaying one implant per vial. The label includes the NDC 73372-0116-1, indicates sterile and prescription-only status, and shows the manufacturer as CLINUVEL INC. It specifies the product is for subcutaneous use, with directions to see the package insert for dosing and administration.*

FDA Label Image

Step 2 (Step 2)

An illustration showing a person reclining on a medical chair or bed while a healthcare professional wearing gloves palpates the person's abdomen or side, demonstrating a step likely related to preparation for a subcutaneous implant administration.*

FDA Label Image

Step 3 (Step 3)

An illustration showing gloved hands administering a SCENESSE (afamelanotide) 16 mg subcutaneous implant by injection into the skin of the arm.*

FDA Label Image

Step 4 (Step 4)

An instructional diagram showing the subcutaneous implantation technique for SCENESSE (afamelanotide) implant. The illustration depicts a hand inserting an implant under the skin at a 30-degree angle to a depth of 2 cm, demonstrating the correct procedure for implant placement.*

FDA Label Image

Step 5 (Step 5)

An instructional illustration showing a gloved hand holding a syringe and preparing to insert an implant subcutaneously into a patient's thigh, demonstrating the subcutaneous route of administration consistent with SCENESSE afamelanotide implant use.*

FDA Label Image

Step 6 (Step 6)

An instructional illustration showing gloved hands performing a subcutaneous implant procedure on a patient's upper arm. One hand holds the skin taut while the other inserts a device under the skin, representing the administration of SCENESSE (afamelanotide) 16 mg implant.*

FDA Label Image

Step 7 (Step 7)

An instructional illustration showing two gloved hands preparing a skin site for a subcutaneous implant. One hand is pulling the skin taut while the other hand appears to be making short, dashed markings on the skin, possibly indicating the site for implant placement or injection area.*

FDA Label Image

Step 8 (Step 8)

An illustration showing a pair of gloved hands applying a adhesive bandage to the inner forearm of a person. The image demonstrates the step of covering a subcutaneous implant site, relevant for the use of SCENESSE (afamelanotide) 16 mg implant.*

FDA Label Image

Step 9 (Step 9)

An illustration showing a person lying down on a reclining chair with a patch applied to the lower abdomen. Next to the person is a stopwatch icon indicating a 30-minute duration, suggesting the time to remain in position after patch application.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.